Cipla ups fight against Covid, launches ‘Covi-G’ for rapid antibody detection
Cipla Limited has inked a licensing agreement with a Belgium-based Multi G for the distribution of the latter's Covid-19 Rapid Antibody test kit.
As per...
Sun Pharmaceutical declares 5-yr positive results for ILUMYA
Pharma major Sun Pharmaceutical Industries Limited has announced that one of its wholly owned subsidiaries presented positive, five-year Phase 3 data for ILUMYA (tildrakizumab-asmn)...
Alembic Pharma gets USFDA nod for Palbociclib Capsules
Alembic Pharmaceuticals Limited has announced receiving tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Palbociclib...
Dr Reddy’s partnership for Sputnik V vaccine clinical trials in India
Dr. Reddy’s Laboratories has forged a partnership with Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology (DBT), Government of India, for advisory support...
Glenmark Pharmaceuticals gets approvals from USFDA for generic Prograf capsules
Glenmark Pharmaceuticals Inc., USA has received final approval by the United States Food & Drug Administration (USFDA) for Tacrolimus Capsules USP, 0.5 mg, 1...
NIH & BARDA react to emergency use authorisation of Moderna Covid-19 vaccine by FDA
NIH and BARDA have reacted to the United States Food and Drug Administration's Emergency Use Authorization (EUA) to Moderna, Inc., a biotechnology company based...
Biocon Biologics gets $150 mn capital dose from Goldman Sachs
The Board of Biocon Biologics Ltd has approved a Rs 1,125 Crore (~USD 150 million) capital injection from Goldman Sachs.
Biocon Biologics is a subsidiary...
Obstructive sleep apnea ups risk for long COVID
Among the Covid-19 hit people,, adults with obstructive sleep apnea were more likely to experience long-term symptoms suggestive of long COVID than those without...
GSK and Medicago commence Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate
Medicago and GSK have announced the beginning of Phase 2/3 clinical trials of plant-derived vaccine candidate for Covid-19.
The study is being done to assess...
Bharat Biotech’s Odisha facility to make 10 types of vaccines including for Covid-19, Malaria
Bharat Biotech International Ltd (BBIL), a Hyderabad based pharma major, has said it would manufacture 10 types of vaccines. These would be produced in...
